Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A concentration for dry eye disease via medial lower eyelid injection
TCTR20221004007Phase 3Completed
- Sponsor
- Naresuan University
- Start
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in dry eye syndrome (DED), sponsored by Naresuan University. Started Aug 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on TCTR20221004007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221004007.